Nelsen Biomedical is pleased to announce that they will attend three cell and gene therapy conferences this fall and moderate two panel discussions focused on… Read more
News & Events
Four years after Emily Whitehead was treated with chimeric antigen receptor T (CAR-T) cell therapy for acute lymphoblastic leukemia (ALL), she remains cancer free. With… Read more
In 2012, the striking clinical success of chimeric antigen receptor T (CAR-T) cell therapy in treating acute lymphoblastic leukemia (ALL) in the case of Emily… Read more
From seed stage through exit, convertible debt to reverse merger, funding strategies are critical for companies to secure the capital necessary for success. To help… Read more
Nelsen Biomedical is pleased to announce that Brittni Peterson will join the team as a full-time employee. Brittni has been working as an intern with… Read more